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Detection of foreign DNA in the cell cytosol triggers potent antiviral responses. In this issue of Immunity, Li
et al. (2013) provide new structural and biochemical data indicating that a cytosolic DNA sensor, cyclic
GMP-AMP synthase (cGAS), is activated by DNA-induced dimerization.Detection of foreign nucleic acids is a
major strategy by which the innate im-
mune system senses infection. Endocy-
tosed nucleic acids, including DNA and
RNA, are detected by Toll-like receptors
(TLRs), and several distinct receptors
detect nucleic acids in the cytosol. For
example, double-stranded RNA (dsRNA)
is detected by multiple sensors—
including protein kinase R (PKR), 20,50
oligoadenylate synthase 1 (OAS1), and
RIG-I-like receptors (RLRs)—that to-
gether activate diverse antiviral re-
sponses. In contrast, cytosolic dsDNA
activates inflammasome responses via
the AIM2 receptor, and in addition, stimu-
lates production of type I interferons
(IFNs), a family of antiviral cytokines.
However, until recently, the mechanism
linking cytosolic dsDNA to IFN production
remained mysterious. In a landmark dis-
covery late last year, James Chen and
colleagues found that the enzyme cyclic
GMP-AMP synthase (cGAS) functions as
a cytosolic dsDNA sensor (Sun et al.,
2013). Upon engagement of cytoplasmic
dsDNA, cGAS synthesizes a unique
second messenger, a cyclic GMP-AMP
dinucleotide (cGAMP), which binds and
activates a downstream endoplasmic
reticulum adaptor called STING. Once
activated, STING initiates a TBK1-IRF3-
dependent innate immune signaling
cascade that culminates in transcription
of type I IFNs and other antiviral genes.
Since the discovery of cGAS, efforts
have been underway to determine the
mechanisms of DNA-dependent activa-
tion and cGAMP production and to under-
stand how cGAS relates to the known
pantheon of cellular nucleic acid sensors.
A flurry of reports earlier this year
described crystal structures of mouse
(Gao et al., 2013), porcine (Civril et al.,
2013), and human (Kranzusch et al.,992 Immunity 39, December 12, 2013 ª20132013) enzymes, revealing a bilobed
cGAS architecture comprising N-terminal
nucleotidyltransferase and C-terminal
dsDNA recognition domains. These
cGAS structures bear remarkable similar-
ity to the cytosolic dsRNA sensor OAS1,
indicating that OAS and cGAS proteins
constitute a new evolutionarily related
family of OAS-like receptors (OLRs)
involved in host defense (Civril et al.,
2013; Kranzusch et al., 2013). Surpris-
ingly, early biochemical follow-up to
the discovery of cGAS showed that its
cyclic dinucleotide product contains
a specific combination of 20,50 and 30,50
glycosidic linkages (cyclic[G(20,50)
pA(30,50)p]; hereafter called 20,50 cGAMP)
(Ablasser et al., 2013; Diner et al., 2013;
Gao et al., 2013; Zhang et al., 2013).
20,50 cGAMP is a more broadly potent
activator of STING than is canonical 30,50
cGAMP (Ablasser et al., 2013; Diner
et al., 2013; Zhang et al., 2013). Crystal
structures of mammalian cGAS bound to
dsDNA and dinucleotide (Civril et al.,
2013; Gao et al., 2013) detail conforma-
tional changes induced by dsDNA that
activate the enzyme core. However, these
complexes include short 14–17 basepair
dsDNA fragments that do not induce
maximal stimulation, and a detailed
picture of the complex pathway of 20,50
cGAMP synthesis remains incomplete.
In this issue of Immunity, Li et al. (2013)
reveal a new dimerization interface within
cGAS that is critical for enzyme activation.
Through careful structural analysis of both
human cGAS alone and mouse cGAS
bound to dsDNA, Li et al. (2013) identify
protein dimerization interactions and a
second DNA binding surface. These
findings extend our understanding of
cGAS enzymatic activation and suggest
a further layer of control over DNA-de-
pendent innate immune signaling.Elsevier Inc.Previous structures of mouse and
porcine cGAS bound to dsDNA focused
on a primary DNA-binding platform
formed by a long N-terminal helical
extension in cGAS and a zinc-ribbon
insertion within the C-terminal domain
(Civril et al., 2013; Gao et al., 2013). The
new interactions characterized by Li
et al. (2013) now include a second DNA-
binding surface and protein-dimerization
interactions located on the opposite face
of the cGAS enzyme within the C-terminal
domain. The secondary DNA-binding site,
involving conserved charged residues,
covers a large area of the cGAS enzyme.
As an indication that these interactions
are not simply a consequence of unique
crystallization conditions, Li et al. (2013)
point out that previously published str-
uctures of cGAS also exhibit C-terminal
dimerization contacts, including a mouse
cGAS-DNA structure that crystallized as
two copies within the asymmetric unit of
the crystal (Gao et al., 2013).
In Li et al. (2013)’s new crystal forms
of cGAS, the potential dimerization
contacts are observed between the zinc-
ribbon and C-terminal domains of closely
packed protein molecules. Crystal growth
is inherently dependent on packing
interactions between molecules, and
therefore additional experimental support
is required to determine whether these
interactions are biologically relevant or
merely the result of crystallization con-
ditions. To verify DNA-induced cGAS
dimerization, Li et al. (2013) first employ
small-angle X-ray scattering (SAXS) to
probe the size and shape of cGAS
complexes in solution. SAXS data are
particularly useful as an adjunct to crys-
tallography, because the profile of elastic
scattering of X-rays can be used to
calculate a molecular envelope and
distinguish the occurrence of potential
Figure 1. RNA and DNA-Induced Oligomerization of Innate Immune Receptors
Analogous to ligand-induced oligomerization within TLR3-dsRNA and AIM2-dsDNA complexes, Li et al.
(2013) report new dimerization interactions within the cytosolic DNA-sensor cGAS. cGAS contains two
unique DNA-binding sites and requires engagement of both surfaces for full activation. Figure models
adapted from PDB entries 3CIY and 3RN2.
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Previewscrystallographic complexes in solution. Li
et al. (2013)’s data indicate that a larger-
than-monomeric complex forms upon
DNA engagement, and the calculated
molecular envelope agrees with the 2:2
dimeric cGAS-DNA complex observed in
the crystal structure. As further support
of dimerization in solution, Li et al. (2013)
determine the molecular mass of cGAS-
DNA complexes by using analytical
ultracentrifugation. The calculated mass
of sedimented cGAS complexes confirms
enhanced dimer formation in the pres-
ence of DNA and additionally reveals
potential formation of higher oligomeric
species.
What role does the secondary DNA-
binding site and cGAS dimerization play
in enzyme activation and innate immune
signaling? To address this question, Li
et al. (2013) purify mouse cGAS variants
encoding key mutations designed to
disrupt each site of DNA binding or the
dimerization interface. In agreement with
prior studies, residues in the primary
DNA binding site, including conserved
basic residues along the N-terminal helix
and within the zinc-ribbon domain, are
essential for enzyme activation (Civril
et al., 2013; Gao et al., 2013; Kato et al.,
2013; Kranzusch et al., 2013). However,
Li et al. (2013) demonstrate that mutations
to the secondary DNA binding site and
dimerization interface also disrupt
enzyme activation. Importantly, some
mutations that disrupt enzyme dimeriza-
tion do not impair 1:1 cGAS-DNA inter-
action, indicating that these mutations
do not destabilize the overall protein
structure. Li et al. (2013) further confirm
the importance of conserved amino acidswithin the secondary DNA binding site
by demonstrating that mutations to this
region abolish interferon-beta reporter
signaling in a cell-based assay, suggest-
ing that DNA-induced dimerization is
critical for full enzyme activation.
Oligomerization appears to be a
general engineering principle in path-
ogen-sensor proteins. TLRs and PKR
are well-characterized examples of di-
merized ligand-bound complexes, and
recent reports also implicate oligomeri-
zation in activation of signaling by RIG-I,
MDA-5, AIM2, and inflammasome
components (reviewed in Wu, 2013)
(Figure 1). The addition of cGAS to the
growing list of innate sensors requiring
oligomerization for full activation suggests
that innate immune signaling receptors
have evolved high-order complex for-
mation to both safeguard the cell from
aberrant activation and to augment
signal transduction upon accurate ligand
identification. Additionally, Li et al.
(2013)’s discovery of cGAS dimerization
may foretell a yet undiscovered role of
oligomerization in dsRNA sensing by
OAS1 and additional members of
the evolutionarily related OLR enzyme
superfamily.
In contrast to the structure of dimer-
ized TLRs bound to nucleic acid du-
plexes, the nearly parallel DNA binding
sites presented in the mouse cGAS-
DNA structure by Li et al. (2013) indicate
that a cGAS dimer cannot assemble
along a single short dsDNA duplex
(Figure 1). cGAS dimers must therefore
form around two separate DNA duplexes
or possibly on a single DNA duplex that
is long enough to bend and occupy eachImmunity 39, DcGAS-binding site. Further confounding
the situation, in the structure presented
by Li et al. (2013), extension of the two
18 base-pair DNA duplexes would result
in a steric clash in one direction. Perhaps
these limitations prevent inappropriate
cGAS signaling by requiring multiple
DNA ligands for activation or specific
binding of cGAS at the ends of a longer
piece of dsDNA, as would be present in
some viral and bacterial genomes.
All structures of cGAS to date contain
the enzyme’s catalytic and dsDNA re-
cognition domains but lack its 150 amino
acid N-terminal tail. This tail is required
for high-affinity human cGAS-DNA
interactions (Kranzusch et al., 2013), and
regions of the tail are capable of inter-
acting independently with dsDNA in
cells (Sun et al., 2013). Perhaps the
N-terminal tail becomes ordered upon
DNA binding or plays a role in facilitating
the dimerized conformation or limiting
further oligomerization. The functional or
regulatory role of the cGAS N-terminal
tail will require future cellular and
biochemical studies.
The discovery of cGAS represents
a major advance in our understanding
of the immune response to foreign
DNA. Identification of the unique 20,50
cGAMP nucleotide produced by acti-
vated cGAS (Ablasser et al., 2013; Diner
et al., 2013; Gao et al., 2013; Zhang
et al., 2013) suggests strategies for
therapeutic intervention in this important
innate immune signaling pathway, and
cGAS enzymatic activity is also an
attractive target for pharmacological
inhibition in systemic lupus erythemato-
sus and other DNA-specific autoimmune
diseases. Identification of DNA-induced
dimerization adds an important new twist
to our understanding of cGAS, with many
more surprises likely to emerge in this
fast-moving field.REFERENCES
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In this issue of Immunity, a study by Luoma et al. (2013) provides structural evidence for direct interactions of
human Vd1+ T cell receptors with CD1d, capping a long trail of evidence that CD1 might be a major influence
on gd T cell biology.gd T cells have proved to be a difficult nut
to crack. Prior to the cloning of the T cell
receptor (TCR) g chain, the cells’ very ex-
istence was not anticipated, and, 30 years
later, we remain uncertain as to why they
are conserved in seemingly all higher ver-
tebrates. Is it because gd cells ‘‘see’’
things that ab T cells and B cells do not?
Although the gd TCR is not restricted to
recognizing antigenic peptides presented
by major histocompatibility complex
(MHC) molecules, it has remained unclear
whether a substantial fraction of the gd
repertoire is shaped by one or more alter-
native antigen-presenting structures.
In seeking an answer among ‘‘uncon-
ventional’’ MHC molecules, many of
which are of unknown function, a non-
peptide binding, MHC class I-related
molecule, T22, was shown to directly
bind the gd TCR of a clone, G8, and to
likewise engage 0.5% of splenic and
gut-associated murine gd T cells (Adams
et al., 2005). Given this, numerous studies
have investigated whether the remaining
gd T cells include specificities for other
members of the extended MHC family,
including CD1. Now two papers, including
one in this issue of Immunity by Luoma
et al. (2013), provide structural evidence
that human Vd1+ TCR can directly bind
CD1d-lipid complexes.In humans, CD1 exists in four cell-
surface-displayed forms (CD1a–CD1d),
but only as CD1d in mice. Like MHC,
CD1 can carry diverse cargoes, although
these are lipids rather than peptides.
CD1c recognition by a cytolytic human
gd T cell line expressing neither CD4 nor
CD8 was reported 25 years ago (see
Figure 1), but thereafter, studies linking
CD1 and gd T cells have been more spo-
radic. In 2000, CD1c-specific human Vd1
T cell lines were reported, albeit without
biochemical evidence (see Figure 1), while
in a very different context, the incidence of
myocarditis in coxsackie B virus-infected
Balb/c mice was regulated by Vg4+
T cells whose activation depended on
CD1d (Huber et al., 2006). More recently,
murine hepatic gd T cells were shown to
respond to CD1d-presenting cardiolipin,
a major phospholipid of bacterial cell
walls and of host mitochondria (Dieude´
et al., 2011). The implication from
these diverse findings of an underlying
connection between CD1 and gd T cells
was compounded by surface plasmon
resonance data showing that the TCR
from a Vg4Vd5 clone (expanded in a
transplant patient infected with CMV)
binds to the endothelial protein C receptor
(EPCR) (Willcox et al., 2012). EPCR is a
lipid-binding protein, very closely relatedto CD1, although gd TCR bindingwas lipid
independent.
Nonetheless, the association of CD1
with T cells has over the past 20 years
been dominated by the finding that a
complex of CD1d and a-galactosylcera-
mide (a-GalCer) is a common antigen for
semi-invariant, type I TCRab+ natural killer
T (iNKT) cells of humans and mice, added
to which there are non-a-GalCer-reactive,
CD1d-restricted type II NKT cells that are
more variable (Bendelac, 1995). Because
multimeric CD1d-a-GalCer complexes
proved to be powerful in identifying iNKT
cells in different scenarios, researchers
subsequently employed multimers of
CD1 complexed to other lipids, and it
was in this context that gd T cells recently
reentered the spotlight. Sulfatide is a
major glycosphingolipid component of
myelin, immune reactivity to which has
been implicated in multiple sclerosis
(MS). Unexpectedly, the most common
human CD1d-sulfatide multimer-binding
cells in the peripheral blood of healthy in-
dividuals were found to be Vd1+ gd T cells,
which are rare in the peripheral blood but
more common in cord blood and the in-
testine and which reportedly accumulate
in MS lesions (see Figure 1),
Two clones (DP10.7 and AB18.1) reac-
tive to CD1d-sulfatide but not to
